Tag: Anticoagulants

Risks for diabetes complications, mortality lower with non-vitamin K antagonist oral anticoagulants versus warfarin

Almost all hospitalized COVID-19 patients with a bleeding event were receiving mechanical ventilation, full-dose anticoagulation

Adding a P2Y12 inhibitor to a therapeutic dose of heparin does not improve outcomes among non-critically ill patients hospitalized for COVID-19

Frail patients with nonvalvular atrial fibrillation also less likely to receive a direct oral anticoagulant versus warfarin

Prospective cohort study restricted to patients with low-risk subsegmental pulmonary embolism managed without anticoagulation

In patients undergoing knee arthroplasty, postoperative incidence of venous thromboembolism lower with milvexian versus enoxaparin

Among those with increased D-dimer levels, no reduction seen in primary composite outcome at 28 days, but odds of death decreased

For patients hospitalized with COVID-19 who are not critically ill, therapeutic-dose anticoagulation is beneficial

Disparities seen among VA patients both for initiating any anticoagulant therapy and for initiating direct-acting oral anticoagulant use

Apixaban the only direct oral anticoagulant linked to lower adverse event rates than warfarin for patients with atrial fibrillation across frailty levels